Calculating Interview Periods

A foundational step in any STI interview is determining the interview period. This timeframe is crucial for identifying sexual partners who may require testing and treatment. The DI Professional will calculate this period before the interview begins. The interview period represents the maximum possible duration during which the person could have contracted or transmitted the infection.

Module Objective:

To equip DI Professionals with the knowledge and skills necessary to accurately calculate interview periods for persons diagnosed with STIs/HIV.

In this e-learning module learners will:

  • Define interview period and its importance in working with people who are diagnosed with an STI/HIV.
  • Discuss factors affecting interview period length (e.g., STI type, symptoms, risk behaviors).
  • Calculate Interview Periods for Specific STIs using different patient profiles and STI/HIV diagnoses(Primary, Secondary, and Early Latent syphilis, Chlamydia, Gonorrhea, PID, and HIV).

STI Clinical Update-Sacramento and Yolo Counties: Congenital Symposium

In-person only event

Monday, October 28, 2024
9:00AM-3:30PM (PDT)
Sacramento, CA
5.00 CME units at no cost

Please note: This is an in-person only event onsite in Sacramento, CA. Registration is limited to local DIS and clinicians in the Sacramento and Yolo counties region. Registration closes on October 25th at 3:00PM (PDT).

Questions: Please email Clinical Program Manager, Elizabeth Olson, elizabeth.olson@ucsf.edu.

Learning Objectives:

Participants will be able to:

  • Recognize common manifestations of primary and secondary syphilis, compare traditional and reverse screening algorithms, and determine appropriate syphilis staging, treatment, and follow-up.
  • Implement CDC recommendations for CS testing and treatment based on infant and birthing parent labs and exam at the time of delivery, and apply current CDPH syphilis screening guidelines to pregnant people in California.
  • Cite evidence supporting doxy-PEP use, understand CDPH recommendations for doxy-PEP prescribing, and counsel patients on potential risks/benefits and follow-up for this biomedical prevention method.
  • Cite local trend data illustrating increased rates of Congenital Syphilis and syphilis among women, as a rationale for enhanced clinical screening for STIs for people who may become pregnant and during pregnancy.
  • Identify at least two local approaches to congenital syphilis prevention, including how to obtain wrap-around services for pregnant people with syphilis, and resources provided via partnerships with local surveillance programs.

Presenters
Dr. Wyatt Hanft
STI Fellow, California Prevention Training Center & California Department of Public Health, STD Control Branch

Dr. Kurtis Mohr
Public Health Medical Officer, California Department of Public Health, STD Control Branch

Dr. Wyatt Hanft and Dr. Kurtis Mohr

Prenatal Syphilis Screening, Staging, and Management for Congenital Syphilis Prevention

This pocket guide summarizes all the essentials of prenatal syphilis screening, staging, and management with the goal of preventing congenital syphilis. 

various microscopic images of pathogens

July 2024 PrEP Learning Collaborative Injectable PrEP Update

Thursday, July 18, 12-1pm PDT

Slides

Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation). 

Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.

PrEP Learning Collaborative Injectable PrEP Update 7/18/24

Slides

Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation). 

Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.

Thursday, July 18, 12-1pm PDT

STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake

Presented by Drs. Kelly Johnson and Kurtis Mohr
Wednesday, July 24, 2024
11:00AM – 1:00PM (PDT)

CME not available for viewing the webinar recording.

""

Learning Objectives

  • Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
  • Appropriately stage and treat syphilis in both pregnant and non-pregnant people
  • Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments

CAPTC is pleased to announce two job aids, focused on mpox recognition, diagnosis, testing, treatment, and vaccination.

The shorter job aid is called “Mpox Clinical Recognition and Testing Quicksheet: Mpox Presentations vs. Common Exanthems.” It is intended as a print resource, to help facilitate clinical recognition of mpox in health care settings. The longer job aid, “Mpox Clinical Recognition and Testing Overview,” is intended as an electronic resource. It has links to a number of helpful mpox-related resources.

You can find the sources of images used in the quicksheet here:

Mpox Disease Intervention Series

The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention skills by applying knowledge of the complexities and nuances specifically related to mpox DI interviews.

Learning Objectives
By the end of these trainings, you should be able to:

  1. Communicate accurate information about mpox symptoms, transmission, prevention, treatment, and services.
  2. Gain awareness of the lived experiences of gay, bi, other men who have sex with men (MSM), including transgender men, and other trans people as it relates to mpox.
  3. Understand a sex-positive, person-centered approach to taking a sexual history for mpox.
  4. Use motivational interviewing and health coaching tools to support clients in seeking vaccination, screening, or treatment for mpox.
  5. Examine personal and structural biases to reduce stigma during mpox interviews.

STI Clinical Update: Stanislaus County

A half-day, in-person (only) event. Registration limited to surrounding Counties. Registration prioritized for DIS, Clinicians.

Wednesday, May 29, 2024
8:00AM-12:00PM (PDT)

3.75 CME units at no cost

Veteran’s Center

Description:

Stanislaus County has experienced a steep increase in rates of STIs, including congenital syphilis and syphilis among women. Addressing these growing rates is an urgent public health priority that requires innovative partnerships. The Stanislaus County Department of Public Health and the California Prevention Training Center invite community medical providers and stakeholders to participate in this STI Update to enhance their knowledge in diagnosis, treatment, prevention, and control strategies.

Learning Objectives:

  • Describe current epidemiology of STIs, particularly syphilis & congenital syphilis in Stanislaus County
  • Understand CDPH screening recommendations, clinical manifestations, diagnostic approach, staging, and management of syphilis, including among pregnant women and infants.
  • Share best practices among providers that serve populations disproportionately impacted by and at-risk for contracting syphilis and other STIs

Presenters

Dr. Wyatt Hanft
STI Fellow, California Prevention Training Center & California Department of Public Health

Dr. Eric Tang
Clinical Faculty, California Prevention Training Center
Medical & Scientific Affairs Section Chief, STD Control Branch, California Department of Public Health

STI Clinical Update Webinar – Syphilis: A Case-Based Review and Update

March 28, 2024

9:30AM-11:00AM (MT)

Presented by Dr. Kelly Johnson

Please note: CME not available for viewing the webinar recording.

Learning Objectives:

  • List common causes for genital ulcerative disease
  • Interpret results of traditional & reverse syphilis screening algorithms
  • Explain the clinical significance of changes in non-treponemal titers
  • Name a resource for help interpreting different combinations of serologic results